SCHEMBL18800606

SCHEMBL18800606

COc1ccc(Oc2ccc(-c3cncc(N)c3C(=N)N)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NQO2 P16083 2/20 0.43
▸ PRSS1 P07477 1/20 0.41
▸ PRSS2 P07478 1/20 0.41
▸ PRSS3 P35030 1/20 0.41
▸ MAPT P10636 3/20 0.41
▸ MAP4K4 O95819 2/20 0.41
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ CYP11B1 P15538 1/20 0.40
▸ CYP11B2 P19099 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ CHEK2 O96017 1/20 0.39
▸ PARP10 Q53GL7 1/20 0.39
▸ RPS6KA3 P51812 1/20 0.38
▸ BTK Q06187 1/20 0.38
▸ MAPKAPK2 P49137 1/20 0.38
▸ TP53 P04637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18800557 0.96 PRSS1 (0.45) NQO2PRSS1PRSS2PRSS3MAPT
SCHEMBL18800626 0.90 SMN1; SMN2 (0.48) PRSS1PRSS2PRSS3MAPTCYP1A2
SCHEMBL18800739 0.88 MEN1 (0.39) PRSS1PRSS2PRSS3KMT2APARP10
SCHEMBL18800867 0.81 BTK (0.50) PRSS1PRSS2PRSS3MAPTMAP4K4
SCHEMBL18800738 0.80 TDO2 (0.49) PRSS1PRSS2PRSS3MAPTCYP1A2
SCHEMBL18800610 0.80 BTK (0.43) PRSS1PRSS2PRSS3MAPTMAP4K4
SCHEMBL18800873 0.78 SCN5A (0.37) CYP11B1CYP11B2KDR
SCHEMBL18800479 0.75 BTK (0.54) MAP4K4PARP10BTKTSHRALDH1A1
SCHEMBL18800747 0.75 KMT2A (0.46) MAPTCYP1A2CYP3A4CYP2C9KMT2A
SCHEMBL18800716 0.74 PRKCQ (0.37) PRSS1MAPTCYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2789615-B1 Azaindazoles as Btk kinase modulators and use thereof BRISTOL MYERS SQUIBB CO (US) 2017-05-03 — — EP disclosed
Send feedback